Health Plans
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Oral Cancer Drugs Deserve Parity

Margaret Dick Tocknell, for HealthLeaders Media, May 25, 2011

That statement was the cue for a spokesperson at the Pharmaceutical Research and Manufacturers of America to wonder why patients pay a much higher share of total out-of-pocket costs for drugs than other medical services. In a press statement, deputy vice president Karl Uhlendorf said, "data from the Agency for Healthcare Research and Quality show that on average insured patients pay out of pocket about 4% of inpatient hospital costs, 16% of physician costs, and 27% of prescription drug costs."

He added that "given the high cost of these new oral medications, the implications for cancer patients of mandating full parity for oral and injectable chemotherapy medications is still unknown."

Like other disease-based interest groups, the American Cancer Society is keeping an eye on the essential benefits list being developed by the Institute of Medicine as part of the requirements of the Affordable Care Act. The hope is that the list will include some statements in support of evidence-based treatments for cancer that can be used to convince health plans to change their stance on oral cancer drugs.

Doctors aren't sitting around while their patient struggle to pay for these drugs. There are physician groups that lobby manufacturers to get free drugs for patients. And oncologists do have the fall back position of traditional chemotherapy if oral cancer drugs become too cost prohibitive. But physicians will tell you that the advantage of oral cancer medications, in addition to fewer side effects, is that they are more targeted to specific cancers and are often more effective.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "Oral Cancer Drugs Deserve Parity"


Todd Madden (5/25/2011 at 3:44 PM)
Its the same old tired argument. Instead ranting about what health plans or more accurately, employers are covering, why not discuss the high costs of medications? And why more isn't being done to bring done costs either through other markets (Oh Canada) or through regulation. Nothing in the Unaffordable Care Act keeps the costs of drugs down. Yet legislators love to prey on the ingnorence of Americans by continuing to pressure health plans without addressing the root cause of the high costs. Good luck.